- Lobbying
- Lobbying by Hematology/Oncology Pharmacy Association
Lobbying Relationship
Bills mentioned
H.R.1730: Cancer Drug Parity Act of 2019
Sponsor: Brian Higgins (D-N.Y.)
S.741: Cancer Drug Parity Act of 2019
Sponsor: Tina Smith (D-Minn.)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
S.3548: CARES Act
Sponsor: Mitch McConnell (R-Ky.)
H.R.7010: Paycheck Protection Program Flexibility Act of 2020
Sponsor: Dean Phillips (D-Minn.)
H.R.6800: The Heroes Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.8337: Continuing Appropriations Act, 2021 and Other Extensions Act
Sponsor: Nita M. Lowey (D-N.Y.)
H.R.133: Consolidated Appropriations Act, 2021
Sponsor: Henry Cuellar (D-Texas)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeremy Scott | n/a |
Joe Nahra | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate